AI in Healthcare May 14, 2019
Dave Pearson

The simultaneous advances of deep learning and radiomics may soon yield a single unified framework for clinical decision support that has the potential to “completely revolutionize the field of precision medicine.”

That’s the conclusion of two scholars at Johns Hopkins whose analysis of the technologies is running in the journal Expert Review of Precision Medicine and Drug Development.

PhD candidate Vishwa Parekh and radiological science professor Michael Jacobs, PhD, searched the literature for radiomics as well as deep learning and other AI-related terms, along with medical-imaging terminology such as multiparametric MRI, to examine how these research interests are being studied in the context of precision medicine.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Precision Medicine, Provider, Technology
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article